ViCentra hires Reman McDonagh as VP of Global Marketing to drive European growth and prepare U.S. launch for the Kaleido insulin patch pump.

Read the Latest Full News – lnkd.in/dqGN-g5U

#ViCentra #KaleidoInsulinPump #DiabetesTech #MedTech #HealthcareInnovation #GlobalMarketing

ViCentra Welcomes Reman McDonagh as New VP of Global Marketing to Spearhead Diabetes Solutions ViCentra has appointed Reman McDonagh as Vice President of Global Marketing, bringing over 20 years of diabetes experience to elevate the Kaleido insulin patch pump system's market presence across Europe and the U.S.

ViCentra Welcomes Reman McDonagh as New VP of Global Marketing to Spearhead Diabetes Solutions #Netherlands #Utrecht #ViCentra #Kaleido #Reman_McDonagh

ViCentra Secures $98 Million to Expand Kaleido Patch Pump for European Market and U.S. Access ViCentra has raised $98 million to enhance the Kaleido insulin patch pump's commercialization across Europe and prepare for the U.S. market. The funding marks a significant milestone in their growth strategy.

ViCentra Secures $98 Million to Expand Kaleido Patch Pump for European Market and U.S. Access #Netherlands #Utrecht #ViCentra #Kaleido #Insulin_Pump

ViCentra Appoints New Leadership Team to Drive European Expansion and Growth ViCentra announces key leadership appointments as part of its growth strategy in Europe, enhancing its team with industry experts from Dexcom and Medtronic.

ViCentra Appoints New Leadership Team to Drive European Expansion and Growth #Netherlands #Utrecht #ViCentra #Kaleido #Karen_Baxter

Additional $$$ Raises: #ChestnutCarbon $90M Series B ext.; #LIZY €75M ($87.4M) Debt & Equity; #Augment $85M Series A; #Exa $85M Series B; #ViCentra $85M Series D; #CharmTherapeutics $80M Series B; #SEON $80M Series C

Acquisition: #Apple > #WhyLabs’ founding team

ViCentra Secures $85 Million to Expand Production of Innovative Insulin Patch Pump ViCentra has successfully raised $85 million to enhance manufacturing capabilities and commercialize its revolutionary Kaleido insulin patch pump, targeting the U.S. market.

ViCentra Secures $85 Million to Expand Production of Innovative Insulin Patch Pump #Netherlands #Utrecht #Diabetes_Care #ViCentra #Kaleido

ViCentra Appoints Tom Arnold as New CEO, Aiming for Global Expansion Tom Arnold has been named CEO of ViCentra, bringing extensive expertise in medical technology to expand the company's innovative insulin pump, Kaleido.

ViCentra Appoints Tom Arnold as New CEO, Aiming for Global Expansion #Netherlands #Utrecht #ViCentra #Kaleido #Tom_Arnold